Using Imaging to Help Treat Difficult Epilepsy Cases: Marvin Rossi from Rush University Medical Center

Video

There are currently close to three million people in the United States with epilepsy. Of that total, close 500,000 are classified as medication resistant. Work is underway to help bring that number down and help more people with the condition.

There are currently close to three million people in the United States with epilepsy. Of that total, close 500,000 are classified as medication resistant. Work is underway to help bring that number down and help more people with the condition.

Marvin A. Rossi, MD, PhD, from Rush University Medical Center, discussed progress being made in this field during a recent interview with MD Magazine. Rossi, who has been involved in research for epilepsy for close to 30 years, said that while a lot of progress has been made in pharmaceutical and surgical options in recent years, there is still much more work to be done. In order to do that, he said more needs to be learned about the condition so that new treatment options can be found.

Related Videos
3 Barriers to Improving Clozapine Use in Treatment-Resistant Schizophrenia
Evaluating MM120 for GAD with Daniel Karlin, MD, and Reid Robinson, MD, MBA
Daniel Karlin, MD: Prevalence of Undiagnosed Generalized Anxiety Disorder
The Future of DSM-5-TR with APA Members Nitin Gogtay, Maria Oquendo, Jonathan Alpert
Paul Appelbaum, MD: What to Warn Patients When Prescribing Psychedelics in the Future
Clozapine and Second-Generation Antipsychotics for Schizophrenia, with John Kane, MD
Ryan McLaughlin, PhD: Challenges Studying Cannabis to Treat Psychiatric Illness
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
Charles R. Marmar, MD: Blood Biomarkers for PTSD
© 2024 MJH Life Sciences

All rights reserved.